Dr. Ellner is Chief of the Section of Infectious Diseases at Boston Medical Center and Professor of Medicine in the Department of Medicine at Boston University School of Medicine. Dr. Ellner is internationally recognized for his research on tuberculosis and its interactions with HIV infection. He has published more than 250 original articles in the peer-reviewed scientific literature. Dr. Ellner is principal investigator of the recently awarded Clinical Diagnostics Research Consortium from the NIH which will evaluate investigation TB diagnostics in endemic areas.



Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Department of Biostatistics, the Department of Global Health and the Department of Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS and the Epidemiology of Tuberculosis. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS.



Dr. Alland is professor of Medicine at New Jersey Medical School (NJMS) at Rutgers University. He is Chief of Infectious Diseases at NJMS, Director of the UMDNJ Center for Emerging Pathogens, and Associate Dean for Clinical Research at NJMS. He is currently the Scientific Director of the TB – Clinical Diagnostics Research Consortium (CDRC), a member of the Tuberculosis Transformative Science Group of the AIDS Clinical Trials Group Network, and is a member of the NIH Clinical Research and Field Studies (CRFS) study section.



Dr. Hochberg is Assistant Professor of Epidemiology at Boston University School of Public Health. She is a board-certified infectious disease physician and co-directs the Travel Clinic at Boston Medical Center. Dr. Hochberg also sees patients in the International Clinic, Center for Infectious Diseases and on the inpatient consultation service at Boston Medical Center. She received specialized training in parasitic diseases as an Epidemic Intelligence Service Officer at the Centers for Disease Control and Prevention (CDC) in the Division of Parasitic Diseases and has extensive experience working internationally.



Dr. Karen Jacobson is an Assistant Professor of Medicine in the Section of Infectious Diseases, Boston University School of Medicine, with a secondary appointment in the Department of Epidemiology, Boston University School of Public Health.  Dr. Jacobson’s research focuses on the epidemiology of drug resistant tuberculosis, including identification of social, biological, and economic determinants of and risk factors for drug resistance and approaches for improving TB outcomes in resource-limited settings.



Dr. Salgame is professor in the Department of Medicine, Division of Infectious Diseases and the Centre for Emerging Pathogens at New Jersey Medical School (NJMS), Rutgers University. Dr. Salgame leads an experimental research laboratory that studies host immunity to Tuberculosis. She has made important contributions to the field of host immune responses against mycobacterial infections, which includes having been the first to demonstrate the presence of human T-helper 1 and T-helper 2 subsets.



Who we are

  • Facebook Social Icon
  • Twitter Social Icon
  • Instagram Social Icon

© 2017 by International Tuberculosis Institute